Radhika Tripuraneni serves as Executive at Terns Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Radhika Tripuraneni has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 1, 2026 involved receiving (via award) 1,697 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 1, 2026 | TERN | $0 | Award | 1,697 | $N/A | Discretionary |
Radhika Tripuraneni currently holds 1,697 shares of Terns Pharmaceuticals, Inc. (TERN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Radhika Tripuraneni has been a net neutral trader of TERN stock. They have purchased $0 and sold $0 worth of shares.
Radhika Tripuraneni's most recent insider trade was on Feb 1, 2026, when they sold 1,697 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted